Global Thrombin (Human) Market Research Report 2025(Status and Outlook)

March 2025 | 166 pages | ID: GE0F1295CCD4EN
Bosson Research

Abstracts

Report Overview

Thrombin (Human) is a crucial enzyme in the blood coagulation process that plays a significant role in clot formation. It is commonly used in various medical procedures such as surgeries, wound healing, and diagnostics. Thrombin (Human) is typically derived from human plasma or produced through recombinant biotechnology. This product is essential in the healthcare industry for its hemostatic properties, aiding in the control of bleeding during surgical interventions and promoting wound healing. Its applications extend to diverse medical fields, including cardiovascular surgery, orthopedics, and dermatology.

The market for Thrombin (Human) is witnessing a steady growth trajectory driven by several key factors. The increasing number of surgical procedures globally, coupled with the rising prevalence of chronic diseases requiring surgical interventions, is a primary driver of market growth. Moreover, advancements in biotechnology and the development of recombinant thrombin products have expanded the market potential by addressing concerns related to the transmission of blood-borne diseases. Additionally, the growing geriatric population, who are more susceptible to conditions necessitating surgical treatments, is contributing to the expanding demand for Thrombin (Human). Furthermore, the rising awareness among healthcare professionals about the benefits of using thrombin-based products for effective hemostasis is fueling market growth.

This report provides a deep insight into the global Thrombin (Human) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Thrombin (Human) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Thrombin (Human) market in any manner.

Global Thrombin (Human) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Baxter

AMRESCO Inc

BD Biosciences

Life Technologies Corporation

PromoCell GmbH

Sigma-Aldrich Corporation

Vitrolife AB

CSL

Bayer

Grifols

Octapharma

Shanghai RAAS

Hualan Biological

Kedrion

Market Segmentation (by Type)

500IU/Vial

1000IU/Vial

2500IU/Vial

Market Segmentation (by Application)

Biotechnology

Medicine

Microbiology

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Thrombin (Human) Market
• Overview of the regional outlook of the Thrombin (Human) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Thrombin (Human) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Thrombin (Human)
1.2 Key Market Segments
1.2.1 Thrombin (Human) Segment by Type
1.2.2 Thrombin (Human) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Thrombin (Human) Market Overview
2.1 Global Market Overview
2.1.1 Global Thrombin (Human) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Thrombin (Human) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Thrombin (Human) Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Thrombin (Human) Product Life Cycle
3.3 Global Thrombin (Human) Sales by Manufacturers (2020-2025)
3.4 Global Thrombin (Human) Revenue Market Share by Manufacturers (2020-2025)
3.5 Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Thrombin (Human) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Thrombin (Human) Manufacturing Sites, Area Served, Product Type
3.8 Thrombin (Human) Market Competitive Situation and Trends
3.8.1 Thrombin (Human) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Thrombin (Human) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Thrombin (Human) Industry Chain Analysis
4.1 Thrombin (Human) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Thrombin (Human) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Thrombin (Human) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Thrombin (Human) Market
5.7 ESG Ratings of Leading Companies
6 Thrombin (Human) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Thrombin (Human) Sales Market Share by Type (2020-2025)
6.3 Global Thrombin (Human) Market Size Market Share by Type (2020-2025)
6.4 Global Thrombin (Human) Price by Type (2020-2025)
7 Thrombin (Human) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Thrombin (Human) Market Sales by Application (2020-2025)
7.3 Global Thrombin (Human) Market Size (M USD) by Application (2020-2025)
7.4 Global Thrombin (Human) Sales Growth Rate by Application (2020-2025)
8 Thrombin (Human) Market Sales by Region
8.1 Global Thrombin (Human) Sales by Region
8.1.1 Global Thrombin (Human) Sales by Region
8.1.2 Global Thrombin (Human) Sales Market Share by Region
8.2 Global Thrombin (Human) Market Size by Region
8.2.1 Global Thrombin (Human) Market Size by Region
8.2.2 Global Thrombin (Human) Market Size Market Share by Region
8.3 North America
8.3.1 North America Thrombin (Human) Sales by Country
8.3.2 North America Thrombin (Human) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Thrombin (Human) Sales by Country
8.4.2 Europe Thrombin (Human) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Thrombin (Human) Sales by Region
8.5.2 Asia Pacific Thrombin (Human) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Thrombin (Human) Sales by Country
8.6.2 South America Thrombin (Human) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Thrombin (Human) Sales by Region
8.7.2 Middle East and Africa Thrombin (Human) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Thrombin (Human) Market Production by Region
9.1 Global Production of Thrombin (Human) by Region(2020-2025)
9.2 Global Thrombin (Human) Revenue Market Share by Region (2020-2025)
9.3 Global Thrombin (Human) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Thrombin (Human) Production
9.4.1 North America Thrombin (Human) Production Growth Rate (2020-2025)
9.4.2 North America Thrombin (Human) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Thrombin (Human) Production
9.5.1 Europe Thrombin (Human) Production Growth Rate (2020-2025)
9.5.2 Europe Thrombin (Human) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Thrombin (Human) Production (2020-2025)
9.6.1 Japan Thrombin (Human) Production Growth Rate (2020-2025)
9.6.2 Japan Thrombin (Human) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Thrombin (Human) Production (2020-2025)
9.7.1 China Thrombin (Human) Production Growth Rate (2020-2025)
9.7.2 China Thrombin (Human) Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Baxter
10.1.1 Baxter Basic Information
10.1.2 Baxter Thrombin (Human) Product Overview
10.1.3 Baxter Thrombin (Human) Product Market Performance
10.1.4 Baxter Business Overview
10.1.5 Baxter SWOT Analysis
10.1.6 Baxter Recent Developments
10.2 AMRESCO Inc
10.2.1 AMRESCO Inc Basic Information
10.2.2 AMRESCO Inc Thrombin (Human) Product Overview
10.2.3 AMRESCO Inc Thrombin (Human) Product Market Performance
10.2.4 AMRESCO Inc Business Overview
10.2.5 AMRESCO Inc SWOT Analysis
10.2.6 AMRESCO Inc Recent Developments
10.3 BD Biosciences
10.3.1 BD Biosciences Basic Information
10.3.2 BD Biosciences Thrombin (Human) Product Overview
10.3.3 BD Biosciences Thrombin (Human) Product Market Performance
10.3.4 BD Biosciences Business Overview
10.3.5 BD Biosciences SWOT Analysis
10.3.6 BD Biosciences Recent Developments
10.4 Life Technologies Corporation
10.4.1 Life Technologies Corporation Basic Information
10.4.2 Life Technologies Corporation Thrombin (Human) Product Overview
10.4.3 Life Technologies Corporation Thrombin (Human) Product Market Performance
10.4.4 Life Technologies Corporation Business Overview
10.4.5 Life Technologies Corporation Recent Developments
10.5 PromoCell GmbH
10.5.1 PromoCell GmbH Basic Information
10.5.2 PromoCell GmbH Thrombin (Human) Product Overview
10.5.3 PromoCell GmbH Thrombin (Human) Product Market Performance
10.5.4 PromoCell GmbH Business Overview
10.5.5 PromoCell GmbH Recent Developments
10.6 Sigma-Aldrich Corporation
10.6.1 Sigma-Aldrich Corporation Basic Information
10.6.2 Sigma-Aldrich Corporation Thrombin (Human) Product Overview
10.6.3 Sigma-Aldrich Corporation Thrombin (Human) Product Market Performance
10.6.4 Sigma-Aldrich Corporation Business Overview
10.6.5 Sigma-Aldrich Corporation Recent Developments
10.7 Vitrolife AB
10.7.1 Vitrolife AB Basic Information
10.7.2 Vitrolife AB Thrombin (Human) Product Overview
10.7.3 Vitrolife AB Thrombin (Human) Product Market Performance
10.7.4 Vitrolife AB Business Overview
10.7.5 Vitrolife AB Recent Developments
10.8 CSL
10.8.1 CSL Basic Information
10.8.2 CSL Thrombin (Human) Product Overview
10.8.3 CSL Thrombin (Human) Product Market Performance
10.8.4 CSL Business Overview
10.8.5 CSL Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Thrombin (Human) Product Overview
10.9.3 Bayer Thrombin (Human) Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Grifols
10.10.1 Grifols Basic Information
10.10.2 Grifols Thrombin (Human) Product Overview
10.10.3 Grifols Thrombin (Human) Product Market Performance
10.10.4 Grifols Business Overview
10.10.5 Grifols Recent Developments
10.11 Octapharma
10.11.1 Octapharma Basic Information
10.11.2 Octapharma Thrombin (Human) Product Overview
10.11.3 Octapharma Thrombin (Human) Product Market Performance
10.11.4 Octapharma Business Overview
10.11.5 Octapharma Recent Developments
10.12 Shanghai RAAS
10.12.1 Shanghai RAAS Basic Information
10.12.2 Shanghai RAAS Thrombin (Human) Product Overview
10.12.3 Shanghai RAAS Thrombin (Human) Product Market Performance
10.12.4 Shanghai RAAS Business Overview
10.12.5 Shanghai RAAS Recent Developments
10.13 Hualan Biological
10.13.1 Hualan Biological Basic Information
10.13.2 Hualan Biological Thrombin (Human) Product Overview
10.13.3 Hualan Biological Thrombin (Human) Product Market Performance
10.13.4 Hualan Biological Business Overview
10.13.5 Hualan Biological Recent Developments
10.14 Kedrion
10.14.1 Kedrion Basic Information
10.14.2 Kedrion Thrombin (Human) Product Overview
10.14.3 Kedrion Thrombin (Human) Product Market Performance
10.14.4 Kedrion Business Overview
10.14.5 Kedrion Recent Developments
11 Thrombin (Human) Market Forecast by Region
11.1 Global Thrombin (Human) Market Size Forecast
11.2 Global Thrombin (Human) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Thrombin (Human) Market Size Forecast by Country
11.2.3 Asia Pacific Thrombin (Human) Market Size Forecast by Region
11.2.4 South America Thrombin (Human) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Thrombin (Human) by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Thrombin (Human) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Thrombin (Human) by Type (2026-2033)
12.1.2 Global Thrombin (Human) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Thrombin (Human) by Type (2026-2033)
12.2 Global Thrombin (Human) Market Forecast by Application (2026-2033)
12.2.1 Global Thrombin (Human) Sales (K MT) Forecast by Application
12.2.2 Global Thrombin (Human) Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Thrombin (Human) Market Size Comparison by Region (M USD)
Table 5. Global Thrombin (Human) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Thrombin (Human) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Thrombin (Human) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Thrombin (Human) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin (Human) as of 2024)
Table 10. Global Market Thrombin (Human) Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Thrombin (Human) Manufacturing Sites and Area Served
Table 12. Manufacturers Thrombin (Human) Product Type
Table 13. Global Thrombin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Thrombin (Human) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Thrombin (Human) Sales by Type (K MT)
Table 25. Global Thrombin (Human) Market Size by Type (M USD)
Table 26. Global Thrombin (Human) Sales (K MT) by Type (2020-2025)
Table 27. Global Thrombin (Human) Sales Market Share by Type (2020-2025)
Table 28. Global Thrombin (Human) Market Size (M USD) by Type (2020-2025)
Table 29. Global Thrombin (Human) Market Size Share by Type (2020-2025)
Table 30. Global Thrombin (Human) Price (USD/MT) by Type (2020-2025)
Table 31. Global Thrombin (Human) Sales (K MT) by Application
Table 32. Global Thrombin (Human) Market Size by Application
Table 33. Global Thrombin (Human) Sales by Application (2020-2025) & (K MT)
Table 34. Global Thrombin (Human) Sales Market Share by Application (2020-2025)
Table 35. Global Thrombin (Human) Market Size by Application (2020-2025) & (M USD)
Table 36. Global Thrombin (Human) Market Share by Application (2020-2025)
Table 37. Global Thrombin (Human) Sales Growth Rate by Application (2020-2025)
Table 38. Global Thrombin (Human) Sales by Region (2020-2025) & (K MT)
Table 39. Global Thrombin (Human) Sales Market Share by Region (2020-2025)
Table 40. Global Thrombin (Human) Market Size by Region (2020-2025) & (M USD)
Table 41. Global Thrombin (Human) Market Size Market Share by Region (2020-2025)
Table 42. North America Thrombin (Human) Sales by Country (2020-2025) & (K MT)
Table 43. North America Thrombin (Human) Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Thrombin (Human) Sales by Country (2020-2025) & (K MT)
Table 45. Europe Thrombin (Human) Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Thrombin (Human) Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Thrombin (Human) Market Size by Region (2020-2025) & (M USD)
Table 48. South America Thrombin (Human) Sales by Country (2020-2025) & (K MT)
Table 49. South America Thrombin (Human) Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Thrombin (Human) Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Thrombin (Human) Market Size by Region (2020-2025) & (M USD)
Table 52. Global Thrombin (Human) Production (K MT) by Region(2020-2025)
Table 53. Global Thrombin (Human) Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Thrombin (Human) Revenue Market Share by Region (2020-2025)
Table 55. Global Thrombin (Human) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Thrombin (Human) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Thrombin (Human) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Thrombin (Human) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Thrombin (Human) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Baxter Basic Information
Table 61. Baxter Thrombin (Human) Product Overview
Table 62. Baxter Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Baxter Business Overview
Table 64. Baxter SWOT Analysis
Table 65. Baxter Recent Developments
Table 66. AMRESCO Inc Basic Information
Table 67. AMRESCO Inc Thrombin (Human) Product Overview
Table 68. AMRESCO Inc Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. AMRESCO Inc Business Overview
Table 70. AMRESCO Inc SWOT Analysis
Table 71. AMRESCO Inc Recent Developments
Table 72. BD Biosciences Basic Information
Table 73. BD Biosciences Thrombin (Human) Product Overview
Table 74. BD Biosciences Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. BD Biosciences Business Overview
Table 76. BD Biosciences SWOT Analysis
Table 77. BD Biosciences Recent Developments
Table 78. Life Technologies Corporation Basic Information
Table 79. Life Technologies Corporation Thrombin (Human) Product Overview
Table 80. Life Technologies Corporation Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Life Technologies Corporation Business Overview
Table 82. Life Technologies Corporation Recent Developments
Table 83. PromoCell GmbH Basic Information
Table 84. PromoCell GmbH Thrombin (Human) Product Overview
Table 85. PromoCell GmbH Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. PromoCell GmbH Business Overview
Table 87. PromoCell GmbH Recent Developments
Table 88. Sigma-Aldrich Corporation Basic Information
Table 89. Sigma-Aldrich Corporation Thrombin (Human) Product Overview
Table 90. Sigma-Aldrich Corporation Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Sigma-Aldrich Corporation Business Overview
Table 92. Sigma-Aldrich Corporation Recent Developments
Table 93. Vitrolife AB Basic Information
Table 94. Vitrolife AB Thrombin (Human) Product Overview
Table 95. Vitrolife AB Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Vitrolife AB Business Overview
Table 97. Vitrolife AB Recent Developments
Table 98. CSL Basic Information
Table 99. CSL Thrombin (Human) Product Overview
Table 100. CSL Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. CSL Business Overview
Table 102. CSL Recent Developments
Table 103. Bayer Basic Information
Table 104. Bayer Thrombin (Human) Product Overview
Table 105. Bayer Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Bayer Business Overview
Table 107. Bayer Recent Developments
Table 108. Grifols Basic Information
Table 109. Grifols Thrombin (Human) Product Overview
Table 110. Grifols Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Grifols Business Overview
Table 112. Grifols Recent Developments
Table 113. Octapharma Basic Information
Table 114. Octapharma Thrombin (Human) Product Overview
Table 115. Octapharma Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Octapharma Business Overview
Table 117. Octapharma Recent Developments
Table 118. Shanghai RAAS Basic Information
Table 119. Shanghai RAAS Thrombin (Human) Product Overview
Table 120. Shanghai RAAS Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Shanghai RAAS Business Overview
Table 122. Shanghai RAAS Recent Developments
Table 123. Hualan Biological Basic Information
Table 124. Hualan Biological Thrombin (Human) Product Overview
Table 125. Hualan Biological Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Hualan Biological Business Overview
Table 127. Hualan Biological Recent Developments
Table 128. Kedrion Basic Information
Table 129. Kedrion Thrombin (Human) Product Overview
Table 130. Kedrion Thrombin (Human) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Kedrion Business Overview
Table 132. Kedrion Recent Developments
Table 133. Global Thrombin (Human) Sales Forecast by Region (2026-2033) & (K MT)
Table 134. Global Thrombin (Human) Market Size Forecast by Region (2026-2033) & (M USD)
Table 135. North America Thrombin (Human) Sales Forecast by Country (2026-2033) & (K MT)
Table 136. North America Thrombin (Human) Market Size Forecast by Country (2026-2033) & (M USD)
Table 137. Europe Thrombin (Human) Sales Forecast by Country (2026-2033) & (K MT)
Table 138. Europe Thrombin (Human) Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Asia Pacific Thrombin (Human) Sales Forecast by Region (2026-2033) & (K MT)
Table 140. Asia Pacific Thrombin (Human) Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. South America Thrombin (Human) Sales Forecast by Country (2026-2033) & (K MT)
Table 142. South America Thrombin (Human) Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Middle East and Africa Thrombin (Human) Sales Forecast by Country (2026-2033) & (Units)
Table 144. Middle East and Africa Thrombin (Human) Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Global Thrombin (Human) Sales Forecast by Type (2026-2033) & (K MT)
Table 146. Global Thrombin (Human) Market Size Forecast by Type (2026-2033) & (M USD)
Table 147. Global Thrombin (Human) Price Forecast by Type (2026-2033) & (USD/MT)
Table 148. Global Thrombin (Human) Sales (K MT) Forecast by Application (2026-2033)
Table 149. Global Thrombin (Human) Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Thrombin (Human)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Thrombin (Human) Market Size (M USD), 2024-2033
Figure 5. Global Thrombin (Human) Market Size (M USD) (2020-2033)
Figure 6. Global Thrombin (Human) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Thrombin (Human) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Thrombin (Human) Product Life Cycle
Figure 13. Thrombin (Human) Sales Share by Manufacturers in 2024
Figure 14. Global Thrombin (Human) Revenue Share by Manufacturers in 2024
Figure 15. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Thrombin (Human) Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Thrombin (Human) Revenue in 2024
Figure 18. Industry Chain Map of Thrombin (Human)
Figure 19. Global Thrombin (Human) Market PEST Analysis
Figure 20. Global Thrombin (Human) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Thrombin (Human) Market Share by Type
Figure 27. Sales Market Share of Thrombin (Human) by Type (2020-2025)
Figure 28. Sales Market Share of Thrombin (Human) by Type in 2024
Figure 29. Market Size Share of Thrombin (Human) by Type (2020-2025)
Figure 30. Market Size Share of Thrombin (Human) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Thrombin (Human) Market Share by Application
Figure 33. Global Thrombin (Human) Sales Market Share by Application (2020-2025)
Figure 34. Global Thrombin (Human) Sales Market Share by Application in 2024
Figure 35. Global Thrombin (Human) Market Share by Application (2020-2025)
Figure 36. Global Thrombin (Human) Market Share by Application in 2024
Figure 37. Global Thrombin (Human) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Thrombin (Human) Sales Market Share by Region (2020-2025)
Figure 39. Global Thrombin (Human) Market Size Market Share by Region (2020-2025)
Figure 40. North America Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Thrombin (Human) Sales Market Share by Country in 2024
Figure 43. North America Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Thrombin (Human) Market Size Market Share by Country in 2024
Figure 45. U.S. Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Thrombin (Human) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Thrombin (Human) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Thrombin (Human) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Thrombin (Human) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Thrombin (Human) Sales Market Share by Country in 2024
Figure 53. Europe Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Thrombin (Human) Market Size Market Share by Country in 2024
Figure 55. Germany Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Thrombin (Human) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Thrombin (Human) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Thrombin (Human) Market Size Market Share by Region in 2024
Figure 68. China Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Thrombin (Human) Sales and Growth Rate (K MT)
Figure 79. South America Thrombin (Human) Sales Market Share by Country in 2024
Figure 80. South America Thrombin (Human) Market Size and Growth Rate (M USD)
Figure 81. South America Thrombin (Human) Market Size Market Share by Country in 2024
Figure 82. Brazil Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Thrombin (Human) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Thrombin (Human) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Thrombin (Human) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Thrombin (Human) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Thrombin (Human) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Thrombin (Human) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Thrombin (Human) Production Market Share by Region (2020-2025)
Figure 103. North America Thrombin (Human) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Thrombin (Human) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Thrombin (Human) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Thrombin (Human) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Thrombin (Human) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Thrombin (Human) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Thrombin (Human) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Thrombin (Human) Market Share Forecast by Type (2026-2033)
Figure 111. Global Thrombin (Human) Sales Forecast by Application (2026-2033)
Figure 112. Global Thrombin (Human) Market Share Forecast by Application (2026-2033)